Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of HealthEquity, Inc. (NASDAQ:HQY)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of HealthEquity, Inc. (NASDAQ:HQY). In a filing disclosed on June 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in HealthEquity stock on May 29th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of SoftBank Group (OTCMKTS:SFTBF) on 6/2/2026.
  • Purchased $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 5/29/2026.
  • Sold $1,001 – $15,000 in shares of AutoZone (NYSE:AZO) on 5/29/2026.
  • Purchased $1,001 – $15,000 in shares of Independent Bank (NASDAQ:INDB) on 5/29/2026.
  • Purchased $1,001 – $15,000 in shares of Arcutis Biotherapeutics (NASDAQ:ARQT) on 5/29/2026.
  • Purchased $1,001 – $15,000 in shares of Boston Scientific (NYSE:BSX) on 5/29/2026.
  • Purchased $1,001 – $15,000 in shares of Perella Weinberg Partners (NASDAQ:PWP) on 5/29/2026.
  • Purchased $1,001 – $15,000 in shares of Cooper Companies (NASDAQ:COO) on 5/29/2026.
  • Purchased $1,001 – $15,000 in shares of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/29/2026.
  • Sold $15,001 – $50,000 in shares of Workday (NASDAQ:WDAY) on 5/29/2026.

HealthEquity Stock Up 0.5%

HealthEquity stock traded up $0.49 during midday trading on Wednesday, reaching $89.72. The company’s stock had a trading volume of 663,235 shares, compared to its average volume of 1,007,371. The company has a market cap of $7.50 billion, a P/E ratio of 33.60, a P/E/G ratio of 1.48 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The business has a 50-day simple moving average of $84.27 and a 200-day simple moving average of $86.03. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $107.66.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HQY has been the subject of several research analyst reports. Jefferies Financial Group set a $108.00 price objective on shares of HealthEquity in a research note on Thursday, February 19th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday. Raymond James Financial set a $100.00 price target on HealthEquity in a research report on Tuesday, February 17th. Finally, Barclays decreased their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $110.57.

View Our Latest Stock Analysis on HQY

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president owned 91,141 shares in the company, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock worth $1,193,000 over the last three months. 1.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Hedge funds and other institutional investors have recently bought and sold shares of the company. NewEdge Advisors LLC increased its stake in shares of HealthEquity by 6.5% during the first quarter. NewEdge Advisors LLC now owns 13,027 shares of the company’s stock worth $1,089,000 after acquiring an additional 796 shares during the period. Axiom Investment Management LLC purchased a new stake in HealthEquity in the 1st quarter valued at approximately $33,000. Summitry LLC increased its position in HealthEquity by 10.3% during the 1st quarter. Summitry LLC now owns 4,371 shares of the company’s stock worth $365,000 after purchasing an additional 408 shares during the period. Bank of America Corp DE raised its stake in shares of HealthEquity by 43.5% during the 1st quarter. Bank of America Corp DE now owns 862,008 shares of the company’s stock worth $72,038,000 after buying an additional 261,150 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in shares of HealthEquity by 3.7% in the 1st quarter. Janus Henderson Group PLC now owns 850,411 shares of the company’s stock valued at $71,068,000 after buying an additional 30,178 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Read More

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.